This paper is in the following e-collection/theme issue:
RCTs - Protocols/Proposals (eHealth) (563) Obstetrics, Gynecology, and Reproductive Medicine (248) Pregnancy Information, Education and Lifestyle Interventions (321)Published on in Vol 11, No 10 (2022): October
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/37452, first published
.

The Fetal Growth Restriction at Term Managed by Angiogenic Factors Versus Feto-Maternal Doppler (GRAFD) Trial to Avoid Adverse Perinatal Outcomes: Protocol for a Multicenter, Open-Label, Randomized Controlled Trial
The Fetal Growth Restriction at Term Managed by Angiogenic Factors Versus Feto-Maternal Doppler (GRAFD) Trial to Avoid Adverse Perinatal Outcomes: Protocol for a Multicenter, Open-Label, Randomized Controlled Trial
Authors of this article:
Pablo Garcia-Manau1








































Altmetric
Altmetric discovers Social Media mentions. Click the ‘See more details’ link for a full report.
Dimensions
Dimensions discovers Citations. Click the ‘details’ link for a full report.